Minosta Tablet is a novel combination medication specifically designed to manage hypocalcemia and osteoporosis in patients with a high risk of fracture. Each tablet contains a unique blend of calcitriol (0.25mcg), calcium carbonate (250mg), and vitamin K2-7 (50mcg). Calcitriol, the active form of vitamin D, helps regulate calcium levels and promotes bone mineralization, while calcium carbonate provides a rapid increase in ionized calcium levels. Vitamin K2-7, a potent vitamin K analog, enhances the activity of osteocalcin, a protein crucial for bone mineralization and density. This synergistic combination effectively treats hypocalcemia by increasing serum calcium levels and mitigates the risk of osteoporotic fractures by promoting bone density and strength. Minosta Tablet is recommended for patients with a history of hypocalcemia, osteoporosis, or high risk of fracture, and is particularly useful for those with impaired gut absorption or malabsorption syndromes. As with any medication, patients should be monitored for potential side effects and efficacy.